PNAS – 2019 Mar
May 28, 2019
Gene-edited stem cells enable CD-33 directed immune therapy for myeloid malignancies. Borot F, Wang H, Ma Y, Jafarov T, Raza A, Ali AM, and Mukherjee S.
Platform
PNAS – 2019 Mar